784 filings
Page 8 of 40
UPLOAD
CRVO
CervoMed Inc
22 Nov 22
Letter from SEC
12:00am
PREC14A
CRVO
CervoMed Inc
18 Nov 22
Preliminary proxy with contested solicitation
5:08pm
8-K
CRVO
CervoMed Inc
18 Nov 22
Diffusion Pharmaceuticals Sees Significant Progress in its Strategic Review Process
4:40pm
DFAN14A
CRVO
CervoMed Inc
18 Nov 22
Additional proxy materials by non-management
11:02am
10-Q
2022 Q3
CRVO
CervoMed Inc
Quarterly report
14 Nov 22
4:10pm
DEFA14A
CRVO
CervoMed Inc
14 Nov 22
Additional proxy soliciting materials
7:41am
8-K
CRVO
CervoMed Inc
14 Nov 22
Diffusion Pharmaceuticals Sees Significant Progress in its Strategic Review Process
7:40am
8-K
CRVO
CervoMed Inc
10 Nov 22
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
5:00pm
4
CRVO
CervoMed Inc
2 Nov 22
Diffusion Pharmaceuticals / Robert Joseph Jr. Cobuzzi ownership change
5:15pm
8-K
CRVO
CervoMed Inc
27 Oct 22
Diffusion Pharmaceuticals Announces Strategic Review Process to Evaluate Value-Enhancing Alternatives including Opportunities to Better Leverage TSC
4:15pm
4
Jane H Hollingsworth
2 Sep 22
Diffusion Pharmaceuticals / Jane H Hollingsworth ownership change
9:06pm
4
Raven Jaeger
26 Aug 22
Diffusion Pharmaceuticals / RAVEN JAEGER ownership change
6:08pm
3
CRVO
CervoMed Inc
26 Aug 22
Diffusion Pharmaceuticals / RAVEN JAEGER ownership change
6:06pm
8-K
CRVO
CervoMed Inc
16 Aug 22
Diffusion Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
4:21pm
S-8
CRVO
CervoMed Inc
12 Aug 22
Registration of securities for employees
4:06pm
10-Q
2022 Q2
CRVO
CervoMed Inc
Quarterly report
11 Aug 22
8:20pm
4
CRVO
CervoMed Inc
3 Aug 22
Diffusion Pharmaceuticals / Robert Joseph Jr. Cobuzzi ownership change
5:52pm
8-K
CRVO
CervoMed Inc
27 Jul 22
Other Events
7:30am
8-K
CRVO
CervoMed Inc
22 Jul 22
Entry into a Material Definitive Agreement
4:20pm
424B5
CRVO
CervoMed Inc
22 Jul 22
Prospectus supplement for primary offering
4:15pm